ID: ALA107525

Max Phase: Preclinical

Molecular Formula: C14H11NO3

Molecular Weight: 241.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NC(=O)c1ccc(-c2ccc(C(=O)O)cc2)cc1

Standard InChI:  InChI=1S/C14H11NO3/c15-13(16)11-5-1-9(2-6-11)10-3-7-12(8-4-10)14(17)18/h1-8H,(H2,15,16)(H,17,18)

Standard InChI Key:  QHLNIHHGHTXGDF-UHFFFAOYSA-N

Associated Targets(non-human)

Human papillomavirus regulatory protein E2 38 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 241.25Molecular Weight (Monoisotopic): 241.0739AlogP: 2.15#Rotatable Bonds: 3
Polar Surface Area: 80.39Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.06CX Basic pKa: CX LogP: 2.13CX LogD: -0.99
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.86Np Likeness Score: -0.37

References

1. Hajduk PJ, Dinges J, Miknis GF, Merlock M, Middleton T, Kempf DJ, Egan DA, Walter KA, Robins TS, Shuker SB, Holzman TF, Fesik SW..  (1997)  NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein.,  40  (20): [PMID:9379433] [10.1021/jm9703404]

Source